期刊文献+

武汉地区汉族人群醛固酮合酶基因多态性与原发性高血压的关系 被引量:8

Association between aldosterone synthase gene polymorphism and primary hypertension in Chinese Han population
原文传递
导出
摘要 目的 :探讨武汉地区汉族人群醛固酮合酶 (CYP11B2 )基因 344C/T多态性频率分布特点及其与原发性高血压 (EH)的关系。方法 :以人群为基础进行EH病例 对照研究 ,应用PCR RELP技术对 2 11例武汉地区汉族人的CYP11B2基因 344C/T多态性进行分析。结果 :武汉地区汉族人群CYP11B2基因 344C/T多态性以TT和CT为主要基因型 ,C等位基因较少见 ,其频率为 2 4 % ,明显低于文献报道的欧洲白种人 (P <0 .0 1) ,亦低于日本人 (P <0 .0 5 )。CYP11B2基因 344C/T多态性与EH无明显相关性 (P >0 .0 5 )。结论 :武汉地区汉族人群CYP11B2基因 344C/T多态性频率分布有着与欧洲白种人以及日本人不同的特点 。 Objective:To investigate the frequency of variant aldosterone synthase (CYP11B2) gene and its relation to primary hypertension in Chinese population.Methods:Population based case control study was conducted using PCR RELP techniques to explore the relation between aldosterone synthase gene polymorphism and primary hypertension in 211 subjects from Chinese Han nationality.Results:Both TT and CT were major frequent genotypes. The frequency of allele C was 0.24 and it was significantly lower in Chinese compared with those reported in Caucations (P< 0.01 ) and in Japanese (P< 0.05 ). There was no significan association between aldosterone synthase gene polymorphism and primary hypertension in the group of 211 Chinese individuals.Conclusion:There is apparent difference in the distribution of C allele frequency of CYP11B2 gene between Chinese Han nationality and other ethnic populations. No significant association is observed for aldosterone synthase allele status and primary hypertension in Chinese Han population.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2003年第8期456-458,共3页 Journal of Clinical Cardiology
关键词 高血压 醛固酮 基因多态性 Hypertension Aldosterone Gene polymorphism
  • 相关文献

参考文献11

  • 1陈爱华,张文秀,唐晓明,李志樑,陆青,钱学贤.醛固酮合成酶基因多态性与高血压及左室肥厚的关系[J].中华内科杂志,2002,41(5):298-301. 被引量:38
  • 2Kupari M, Hautanen A, Lankinen L, et al. Association between human aldosterone synthase (CYP11B2)gene polymorphisms and left ventricular size, mass, and function. Circulation, 1998, 97 : 569-575.
  • 3Curnow K M, Tusie-Luna M T, Pascoe L, et al. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol, 1991, 5:1513--1522.
  • 4Kawamoto T, Mitsuuchi Y, Toda K, et al. Role of steroid 11-betahydroxylase and steroid 18-hydroxylase in the biosynthesis of glueoeortieoids and mineralocoticoids in humans. Proe Natl Aead Sci USA, 1992, 89:1458-1462.
  • 5White P C, Slutsker L. Haplotype analysis of CYP11B2. Endocr Res, 1995, 21:437--442.
  • 6Tamaki S, Iwai N, Tsujita Y, et al. Genetic polymorphism of CYP11B gene and hypertension in Japanese.Hypertension, 1999,33:266-270.
  • 7Hauntanean A, Lankinen L, Kupari M, et al. Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J Intern Med,1998, 244:11-18.
  • 8Komiya I, Yamada T, Takara M, et al. Lys(173)Arg and -344 T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension, 2000, 35.699--703.
  • 9Paillard F, Chansel D, Brand E, et al. Genetype-phenotype relationship for the renin-angiotension-aldosterone system in a normal poulation. Hypertension,1999, 34:423--429.
  • 10Delles C, Erdmann J, Jacobi J, et al. Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular strcture in human arterial hypertension. J Am Coll Cardiol, 2001, 37:878--884.

二级参考文献9

  • 1Devereux RB, Koren MJ, de Simone G, et al. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J ,1993, 14 Suppl D:8-15.
  • 2Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.J Clin Invest, 1990 , 86:1343-1346.
  • 3Kupari M, Hautanen A, Lankinen L, et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation, 1998,97:569-575.
  • 4Brand E, Chatelain N, Mulatero P, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension, 1998,32:198-204.
  • 5Tamaki S,Iwai N,Tsujita Y, et al. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension, 1999, 33:266-270.
  • 6Hautanen A, Toivanen P, Manttari M,et al. Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction.Circulation, 1999,100:2213-2218.
  • 7Tsujita Y, Iwai N, Katsuya T, et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res, 2001, 24:105-109.
  • 8White PC, Hautanen A, Kupari M. Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function. J Steroid Biochem Mol Biol, 1999,69:409-412.
  • 9Young M, Fullerton M, Dilley R, et al. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest, 1994, 93:2578-2583.

共引文献37

同被引文献95

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部